Skin carcinoma
MONDO:0002656A carcinoma that arises from epithelial cells of the zone of skin
Also known as: carcinoma of skin, carcinoma of the skin, carcinoma of zone of skin, non-melanoma cancer of skin, non-melanoma cancer of the skin, non-melanoma skin cancer, nonmelanoma skin cancer, skin cancer, non-melanoma
3031 clinical trials for this condition and its sub-types, 35 tagged with Skin carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin carcinoma
-
Skin squamous cell carcinoma 151 trials · 158 incl. sub-types
9 sub-types
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
- Anal margin squamous cell carcinoma 4 trials
- Acantholytic squamous cell skin carcinoma 1 trial
- Clear cell squamous cell skin carcinoma 1 trial
- Sarcomatoid squamous cell skin carcinoma 1 trial
- Plantar verrucous skin carcinoma 0 trials
- Pseudovascular skin squamous cell carcinoma 0 trials
- Skin adenosquamous carcinoma 0 trials
- Skin basaloid carcinoma 0 trials
-
Cutaneous neuroendocrine carcinoma 78 trials
-
Skin basal cell carcinoma 52 trials · 60 incl. sub-types
25 sub-types
- Nodular basal cell carcinoma 8 trials
- Superficial multifocal basal cell carcinoma 7 trials
- Basosquamous carcinoma 1 trial
- Morpheaform basal cell carcinoma 1 trial
- Skin infiltrative basal cell carcinoma 1 trial
- Adamantinoid basal cell epithelioma 0 trials
- Anal margin basal cell carcinoma 0 trials
- External ear basal cell carcinoma 0 trials
- Follicular atrophoderma-basal cell carcinoma 0 trials
- Follicular basal cell carcinoma 0 trials
- Infundibulocystic basal cell carcinoma 0 trials
- Metatypical basal cell carcinoma 0 trials
- Micronodular basal cell carcinoma 0 trials
- Penis basal cell carcinoma 0 trials
- Salivary gland basal cell adenocarcinoma 0 trials
- Sarcomatoid basal cell carcinoma 0 trials
- Scrotum basal cell carcinoma 0 trials
- Sebaceous basal cell carcinoma 0 trials
- Signet ring basal cell carcinoma 0 trials
- Skin adenoid basal cell carcinoma 0 trials Sub-types →
- Skin clear cell basal cell carcinoma 0 trials
- Skin cystic basal cell carcinoma 0 trials
- Skin fibroepithelial basal cell carcinoma 0 trials
- Skin pigmented basal cell carcinoma 0 trials
- Vulva basal cell carcinoma 0 trials
-
Skin carcinoma in situ 3 trials · 9 incl. sub-types
1 sub-type
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
-
Skin appendage carcinoma 4 trials · 6 incl. sub-types
3 sub-types
- Sebaceous adenocarcinoma 2 trials · 3 incl. sub-types Sub-types →
- Sweat gland carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Skin pilomatrix carcinoma 0 trials
-
Anal margin carcinoma 1 trial · 6 incl. sub-types
3 sub-types
- Anal margin squamous cell carcinoma 4 trials
- Perianal skin Paget disease 1 trial
- Anal margin basal cell carcinoma 0 trials
-
Eyelid carcinoma 1 trial · 2 incl. sub-types
1 sub-type
- Eyelid sebaceous gland carcinoma 1 trial
-
Cutaneous Paget disease 0 trials · 1 incl. sub-types
1 sub-type
- Perianal skin Paget disease 1 trial
-
Cutaneous mucoepidermoid carcinoma 0 trials
-
Labia majora carcinoma 0 trials
-
Labia minora carcinoma 0 trials
-
Vulvar seborrheic keratosis 0 trials
1 sub-type
- Vulvar inverted follicular keratosis 0 trials
Most studied deeper sub-types
-
Cancer-Killing virus combined with immunotherapy shows promise in advanced tumors
Disease control OngoingThis Phase 2 trial tests a genetically modified herpes virus (RP1) alone or with the immunotherapy drug nivolumab in people with advanced solid tumors, including melanoma, non-small cell lung cancer, and certain skin cancers. The study aims to see if the combination is safe and c…
Phase 2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Smart drug schedule may improve melanoma treatment
Disease control OngoingThis early-phase study tested a new way of giving three drugs (encorafenib, binimetinib, and nivolumab) to people with advanced BRAF-mutant melanoma. Instead of taking the drugs every day, participants followed an on/off schedule to see if it could control the cancer while reduci…
Early phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New PET tracer could spot cancers that standard scans overlook
Diagnosis OngoingThis phase 1 trial is testing a new imaging tracer called 68Ga-FAPI-46 to see where it collects in normal and cancerous tissues. About 30 people with various solid tumors or blood cancers will receive the tracer and then undergo a PET/CT scan. The goal is to understand how the tr…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New test could prevent unnecessary surgery for common skin precancers
Diagnosis OngoingThis study aims to create a diagnostic test that can tell the difference between precancerous skin lesions (actinic keratoses) that will turn into skin cancer and those that will go away on their own. Researchers will study tissue samples from 140 patients with skin cancer and pr…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Scientists map skin Cancer's inner workings to decode immunotherapy response
Knowledge-focused OngoingResearchers are studying cutaneous squamous cell carcinoma, a common type of skin cancer, in patients who receive the immunotherapy drug cemiplimab before surgery. The goal is to build a detailed molecular map of the tumor and its surroundings using single-cell sequencing and gen…
Phase 2 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated Sep 21, 2026 16:00 UTC
-
Cancer treatment gets personal: MATCH trial tests Gene-Guided drugs
Knowledge-focused OngoingThis phase II trial, called MATCH, is testing whether treating cancer based on the genetic makeup of a patient's tumor works better than standard treatments. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to prior therapy are …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New study tests if teaching patients and doctors to spot skin cancer early can save lives after transplant
Knowledge-focused OngoingThis study looks at whether teaching stem cell transplant survivors and their primary care doctors about skin cancer screening can lead to earlier detection. Participants receive educational materials and some doctors get a dermatoscope (a magnifying lens). The goal is to see if …
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Scientists use suction blisters to peek inside skin inflammation
Knowledge-focused OngoingThis study aims to understand how inflammation works in the skin and how certain anti-inflammatory drugs (biologics) affect it. Researchers will create small suction blisters on the skin of healthy volunteers and people with skin conditions, then analyze the fluid and cells. The …
Phase 2/3 • Sponsor: Wei-Che Ko • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Danish study checks skin cancer patients years after radiation
Knowledge-focused By invitation onlyThis study invites 2,900 adults who had radiotherapy for non-melanoma skin cancer on the head or neck between 2020 and 2024 to a follow-up visit at least two years later. Participants will fill out a questionnaire about how the treated area looks and have their skin examined. The…
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC